VitaNova Life Sciences Corporation (VNOV)

OTCMKTS · Delayed Price · Currency is USD
1.380
0.00 (0.00%)
Jun 11, 2026, 4:00 PM EST
Market Cap11.51M
Revenue (ttm)3.19M +154.8%
Net Income745.48K +241.4%
EPS0.09 +45.3%
Shares Out 8.34M
PE Ratio15.43
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open1.380
Previous Close1.380
Day's Range1.380 - 1.380
52-Week Range0.423 - 7.500
Beta-0.46
Analystsn/a
Price Targetn/a
Earnings DateJul 24, 2026

About VitaNova Life Sciences

VitaNova Life Sciences Corporation provides business consulting services in the United States, Hong Kong, China, and internationally. It operates through two segments; Consulting Service and Healthcare. The company offers consulting advisory services in management business, accounting, and financial services; anti-aging products; and healthcare products and health consultation services. The company was formerly known as Yijia Group Corp. and changed its name to VitaNova Life Sciences Corporation in January 2026. VitaNova Life Sciences Corporati... [Read more]

Sector Healthcare
Founded 2017
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol VNOV
Full Company Profile

Financial Performance

In fiscal year 2025, VitaNova Life Sciences's revenue was $2.66 million, an increase of 366.47% compared to the previous year's $570,694. Earnings were $850,746, an increase of 503.94%.

Financial Statements